Collectively, these epigenetic regulators—including DNA methylation, histone modifications, and ncRNAs—modulate key aspects of YAP/TAZ function, such as phosphorylate on, ubiquitination, subcellular localization, and transcriptional activity, thereby influencing CRC initiation, progression, and therapeutic response. This evidence concerns the gene YAP1 and colorectal carcinoma.